 Connection
Melanie Everitt to Graft Survival
This is a "connection" page, showing publications Melanie Everitt has written about Graft Survival.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.793 |
|
|
|
-
Everitt MD, Pahl E, Koehl DA, Cantor RS, Kirklin JK, Reed AC, Thrush P, Zinn M, McCormick AD, Yester J, Schauer JS, Lee DW. Clinical outcomes after a biopsy diagnosis of antibody-mediated rejection in pediatric heart transplant recipients. J Heart Lung Transplant. 2025 01; 44(1):82-91.
Score: 0.177
-
Bae EK, Chandran MM, Everitt MD, Benz E, Bock M. LCP-Tacrolimus Extended-Release (Envarsus XR) Use in Adolescent and Young Adult Solid Organ Transplant Recipients. Clin Transplant. 2024 08; 38(8):e15417.
Score: 0.176
-
Khan A, Pahl E, Koehl DA, Cantor RS, Kirklin JK, Rusconi P, Barnes AP, Azeka E, Everitt MD. Improved heart transplant survival for children with congenital heart disease and heterotaxy syndrome in the current era: An analysis from the pediatric heart transplant society. J Heart Lung Transplant. 2021 10; 40(10):1153-1163.
Score: 0.142
-
Kleinmahon JA, Patel SS, Auerbach SR, Rossano J, Everitt MD. Hearts transplanted after circulatory death in children: Analysis of the International Society for Heart and Lung Transplantation registry. Pediatr Transplant. 2017 Dec; 21(8).
Score: 0.109
-
Almond CS, Daly KP, Albers EL, Alejos JC, Ameduri R, Auerbach SR, Barkoff L, Barnes AP, Bock MJ, Butto A, Carlo WF, Castleberry CD, Chrisant MR, Deshpande SR, Dreyer WJ, Everitt MD, Feingold B, Gonzales S, Hollander SA, Kindel SJ, Klein GL, Lal AK, Lamour JM, Lee J, Lu M, Lytrivi ID, Miyamoto SD, Pahl E, Peng DM, Ryan TD, Singh TP, Su JA, Sutcliffe DL, Ybarra AM, Zangwill S, Rossano JW, Sleeper LA. Everolimus and Low-Dose Tacrolimus After Heart Transplant in Children: A Randomized Clinical Trial. JAMA. 2025 Oct 21; 334(15):1339-1348.
Score: 0.048
-
Downs EA, Schäfer M, Everitt MD, Aubrey M, Mitchell M, Jaggers J, Campbell D, Stone ML. Inclusive ABO-Incompatible Listing for Pediatric Heart Transplantation Results in Comparable Post-Transplant Rejection-Free Survival in a Single-Center Series. Pediatr Cardiol. 2025 Oct; 46(7):1925-1931.
Score: 0.044
-
Bansal N, Everitt MD, Nandi D, Spinner J, Conway J, Magnetta DA, Profita EL, Townsend M, Alejos JC, Deshpande SR. Clinical approach to acute cellular rejection from the pediatric heart transplant society. Pediatr Transplant. 2022 12; 26(8):e14393.
Score: 0.039
-
Kirk R, Dipchand AI, Davies RR, Miera O, Chapman G, Conway J, Denfield S, Gossett JG, Johnson J, McCulloch M, Schweiger M, Zimpfer D, Ablonczy L, Adachi I, Albert D, Alexander P, Amdani S, Amodeo A, Azeka E, Ballweg J, Beasley G, Böhmer J, Butler A, Camino M, Castro J, Chen S, Chrisant M, Christen U, Danziger-Isakov L, Das B, Everitt M, Feingold B, Fenton M, Garcia-Guereta L, Godown J, Gupta D, Irving C, Joong A, Kemna M, Khulbey SK, Kindel S, Knecht K, Lal AK, Lin K, Lord K, Möller T, Nandi D, Niesse O, Peng DM, Pérez-Blanco A, Punnoose A, Reinhardt Z, Rosenthal D, Scales A, Scheel J, Shih R, Smith J, Smits J, Thul J, Weintraub R, Zangwill S, Zuckerman WA. ISHLT consensus statement on donor organ acceptability and management in pediatric heart transplantation. J Heart Lung Transplant. 2020 04; 39(4):331-341.
Score: 0.032
-
Almond CS, Hoen H, Rossano JW, Castleberry C, Auerbach SR, Yang L, Lal AK, Everitt MD, Fenton M, Hollander SA, Pahl E, Pruitt E, Rosenthal DN, McElhinney DB, Daly KP, Desai M. Development and validation of a major adverse transplant event (MATE) score to predict late graft loss in pediatric heart transplantation. J Heart Lung Transplant. 2018 04; 37(4):441-450.
Score: 0.026
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|